Literature DB >> 3106975

Purification and characterization of yeast myristoyl CoA:protein N-myristoyltransferase.

D A Towler, S P Adams, S R Eubanks, D S Towery, E Jackson-Machelski, L Glaser, J I Gordon.   

Abstract

Myristoyl CoA:protein N-myristoyltransferase (NMT) catalyzes the addition of myristic acid to the amino-terminal glycine residues of a number of eukaryotic proteins. Recently, we developed a cell-free system for analyzing NMT activity and have begun to characterize the substrate specificity of this enzyme by using a series of synthetic peptides. We have now purified NMT from Saccharomyces cerevisiae to apparent homogeneity. The native enzyme is a 55-kDa protein, exhibits no requirement for divalent cation, and appears to contain a histidine residue critical for enzyme activity. A total of 42 synthetic peptides have been used to define structure/activity relationships in NMT substrates. An amino-terminal glycine is required for acylation; substitution with glycine analogues produces peptides that are inactive as substrates or inhibitors of NMT. A broad spectrum of amino acids is permitted at positions 3 and 4, while strict amino acid requirements are exhibited at position 5. Replacement of Ala5 in the peptide Gly-Asn-Ala-Ala-Ala-Ala-Arg-Arg with Asp ablates the peptide's myristoyl-accepting activity. A serine at this position results in a decrease by a factor of approximately equal to 500 in the apparent Km in the context of three different sequences. Penta- and hexa-peptides are substrates, but with decreased affinity. These studies establish that structural information important for NMT-ligand interaction exists beyond the first two amino acids in peptide substrates and that the side chains of residue 5 play a critical role in the binding of substrates to this enzyme.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106975      PMCID: PMC304727          DOI: 10.1073/pnas.84.9.2708

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Modification of histidyl residues in proteins by diethylpyrocarbonate.

Authors:  E W Miles
Journal:  Methods Enzymol       Date:  1977       Impact factor: 1.600

2.  Myristyl amino-terminal acylation of murine retrovirus proteins: an unusual post-translational proteins modification.

Authors:  L E Henderson; H C Krutzsch; S Oroszlan
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

3.  n-Tetradecanoyl is the NH2-terminal blocking group of the catalytic subunit of cyclic AMP-dependent protein kinase from bovine cardiac muscle.

Authors:  S A Carr; K Biemann; S Shoji; D C Parmelee; K Titani
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

4.  Identification of the NH2-terminal blocking group of calcineurin B as myristic acid.

Authors:  A Aitken; P Cohen; S Santikarn; D H Williams; A G Calder; A Smith; C B Klee
Journal:  FEBS Lett       Date:  1982-12-27       Impact factor: 4.124

5.  Identification of the NH2-terminal blocking group of NADH-cytochrome b5 reductase as myristic acid and the complete amino acid sequence of the membrane-binding domain.

Authors:  J Ozols; S A Carr; P Strittmatter
Journal:  J Biol Chem       Date:  1984-11-10       Impact factor: 5.157

6.  Hepatitis B virus genes and their expression in E. coli.

Authors:  M Pasek; T Goto; W Gilbert; B Zink; H Schaller; P MacKay; G Leadbetter; K Murray
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

7.  Mutant defective in processing of an enzyme located in the lysosome-like vacuole of Saccharomyces cerevisiae.

Authors:  B A Hemmings; G S Zubenko; A Hasilik; E W Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

8.  Covalently bound myristate in a lymphoma tyrosine protein kinase.

Authors:  G A Marchildon; J E Casnellie; K A Walsh; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

9.  In vivo modification of retroviral gag gene-encoded polyproteins by myristic acid.

Authors:  A M Schultz; S Oroszlan
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

10.  Amino terminal myristylation of the protein kinase p60src, a retroviral transforming protein.

Authors:  A M Schultz; L E Henderson; S Oroszlan; E A Garber; H Hanafusa
Journal:  Science       Date:  1985-01-25       Impact factor: 47.728

View more
  83 in total

1.  Cloning, expression and N-terminal myristoylation of CpCPK1, a calcium-dependent protein kinase from zucchini (Cucurbita pepo L.).

Authors:  M Ellard-Ivey; R B Hopkins; T J White; T L Lomax
Journal:  Plant Mol Biol       Date:  1999-01       Impact factor: 4.076

2.  Functional analysis of protein N-myristoylation: metabolic labeling studies using three oxygen-substituted analogs of myristic acid and cultured mammalian cells provide evidence for protein-sequence-specific incorporation and analog-specific redistribution.

Authors:  D R Johnson; A D Cox; P A Solski; B Devadas; S P Adams; R M Leimgruber; R O Heuckeroth; J E Buss; J I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

3.  Structural role of the matrix protein of type D retroviruses in gag polyprotein stability and capsid assembly.

Authors:  S S Rhee; E Hunter
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

Review 4.  Acylation of viral and eukaryotic proteins.

Authors:  R J Grand
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

5.  Poorly expressed endogenous ecotropic provirus of DBA/2 mice encodes a mutant Pr65gag protein that is not myristylated.

Authors:  N G Copeland; N A Jenkins; B Nexø; A M Schultz; A Rein; T Mikkelsen; P Jørgensen
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

6.  Replication of human immunodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acid.

Authors:  M L Bryant; R O Heuckeroth; J T Kimata; L Ratner; J I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

7.  Acylation of monocyte and glomerular mesangial cell proteins. Myristyl acylation of the interleukin 1 precursors.

Authors:  S L Bursten; R M Locksley; J L Ryan; D H Lovett
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

8.  ACBD6 protein controls acyl chain availability and specificity of the N-myristoylation modification of proteins.

Authors:  Eric Soupene; Frans A Kuypers
Journal:  J Lipid Res       Date:  2019-01-14       Impact factor: 5.922

9.  Use of thermal melt curves to assess the quality of enzyme preparations.

Authors:  Gregory J Crowther; Panqing He; Philip P Rodenbough; Andrew P Thomas; Kuzma V Kovzun; David J Leibly; Janhavi Bhandari; Lisa J Castaneda; Wim G J Hol; Michael H Gelb; Alberto J Napuli; Wesley C Van Voorhis
Journal:  Anal Biochem       Date:  2009-12-14       Impact factor: 3.365

10.  Coenzyme A dependent myristoylation and demyristoylation in the regulation of bovine spleen N-myristoyltransferase.

Authors:  R V Raju; R K Sharma
Journal:  Mol Cell Biochem       Date:  1996-05-24       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.